Drug Trial Radar · NCT07003984
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
720
Planned (sponsor's estimate)
Start
Jun 5, 2025
Primary completion
Sep 2028
Study completion Sep 2028
Sponsor
- Lead sponsor
- Bavarian NordicIndustry
- Sponsor type
- Industry
- First posted
- Jun 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year, up to 11 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this multi-center, randomized, double-blind, placebo-controlled study is to evaluate the safety and immunogenicity of CHIKV VLP Vaccine in children 1 to \<12 years of age.
Conditions
- Chikungunya Virus
Interventions
CHIKV VLP vaccineBiological
CHIKV VLP vaccine is comprised of chikungunya virus virus-like particles (CHIKV VLP), adsorbed on aluminum hydroxide (Alhydrogel®) adjuvant 2%
PlaceboBiological
Placebo is comprised of formulation buffer
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Endpoint 3: Incidence of AESI, MAAEs, and SAEsTime frame: From vaccination through the end of the trial, planned to be Day 732 for study completers.
- Primary Immunogenicity Endpoint: Day 22 anti-CHIKV SNA seroresponse rate in seronegative childrenTime frame: Study Day 22, 21 days after vaccination with CHIKV VLP vaccine or placebo.
- Safety Endpoint 2: Incidence of unsolicited AEs through Day 29Time frame: From vaccination on Day 1 through Day 29, 28 days after vaccination with CHIKV VLP vaccine or placebo.
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
ARK Clinical Research, LLC
Fountain Valley, California
Emerson Clinical Research Institute- DC
Washington D.C., District of Columbia
Acevedo Clinical Research
Miami, Florida
Hope Research Network
Miami, Florida
Velocity Clinical Research-Omaha
Omaha, Nebraska
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
KidCare Pediatrics
Beaumont, Texas
Velocity Clinical Research - Salt Lake City
West Jordan, Utah
CARE CT Group Inc.
Dasmariñas, Cavite, Philippines
HIMC Research and Development on Medical Sciences
Imus, Cavite, Philippines
University of the Philippines-Philippine General Hospital
Manila, Cavite, Philippines
Silang Specialist Medical Center
Silang, Cavite, Philippines
University of Perpetual Help DALTA Medical Center, Biomedical Research Institute
Las Piñas, National Capital Region, Philippines
Institute of Child Health and Human Development, University of the Philippines
Manila, National Capital Region, Philippines
CMRC Headlands LLC
San Juan, Puerto Rico, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.